The improvement can likely be credited to the common use of certain diabetes drugs, like GLP-1R agonists and SGLT-2 inhibitors, which have been shown to greatly enhance heart health and reduce death rates [38–40]. This evidence concerns the gene SLC5A2 and diabetes mellitus.